- Community-acquired versus Nosocomial Klebsiella pneumonia Bacteremia: Clinical Features, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance
-
Vandijck D, Decruyenaere JM, Depuydt PO, Blot SI
- KMID: 1127105
- J Korean Med Sci.
- 2007 Aug;22(4):770-771.
- doi: 10.3346/jkms.2007.22.4.770
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Community-Acquired versus Nosocomial Klebsiella pneumoniae Bacteremia: Clinical Features, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance
-
Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW
- KMID: 1781898
- J Korean Med Sci.
- 2006 Oct;21(5):816-822.
- doi: 10.3346/jkms.2006.21.5.816
We conducted this study to compare clinical features, outcomes, and clinical implication of antimicrobial resistance in Klebsiella pneumoniae bacteremia acquired as community vs. nosocomial infection. A total of 377 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Gastric Wall Abscess
-
Lee JY, Choi SC, Seo GS
- KMID: 1792792
- Korean J Gastroenterol.
- 2011 May;57(5):327-329.
- doi: 10.4166/kjg.2011.57.5.327
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007
-
Lee K, Lee MA, Lee CH, Lee J, Roh KH, Kim S, Kim JJ, Koh E, Yong D, Chong Y, KONSAR Group
- KMID: 1779638
- Yonsei Med J.
- 2010 Nov;51(6):901-911.
- doi: 10.3349/ymj.2010.51.6.901
PURPOSE: Antimicrobial resistance monitoring could be a useful source of information for treating and controlling nosocomial infections. We analyzed antimicrobial resistance data generated by Korean Hospitals and by a commercial... -
- CITED
-
- Close
- SHARE
-
- Close
- The Resistance Mechanism and Clonal Distribution of Tigecycline-Nonsusceptible Klebsiella pneumoniae Isolates in Korea
-
Ahn C, Yoon SS, Yong TS, Jeong SH, Lee K
- KMID: 2374083
- Yonsei Med J.
- 2016 May;57(3):641-646.
- doi: 10.3349/ymj.2016.57.3.641
PURPOSE: Tigecycline is one of the drugs used to treat multi-drug resistant Klebsiella pneumoniae (K. pneumoniae) infections, including complicated skin and soft tissue infections, complicated intra-abdominal infection, and community-acquired pneumonia... -
- CITED
-
- Close
- SHARE
-
- Close
